Cost-effectiveness analysis of first-line treatment for chronic hepatitis B in China
Zonglin Dai, Irene Ol Wong, Chan Xie, Wenxiong Xu, Yu Xiang, Liang Peng, Eric H. Y. Lau
Topics & Concepts
EntecavirMedicinePegylated interferonCost effectivenessHBeAgHBsAgCost-effectiveness analysisInternal medicineHepatitis B virusChronic hepatitisImmunologyVirusLamivudineRisk analysis (engineering)RibavirinHepatitis B Virus StudiesHepatitis C virus researchHIV/AIDS drug development and treatment